nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—Diazepam—epilepsy syndrome	0.289	1	CrCtD
Amoxapine—GABRA1—epilepsy syndrome	0.0433	0.219	CbGaD
Amoxapine—CHRM1—epilepsy syndrome	0.0404	0.204	CbGaD
Amoxapine—HTR7—epilepsy syndrome	0.0328	0.166	CbGaD
Amoxapine—ADRA2A—epilepsy syndrome	0.0281	0.142	CbGaD
Amoxapine—SLC6A4—epilepsy syndrome	0.0215	0.109	CbGaD
Amoxapine—GABRA1—Clonazepam—epilepsy syndrome	0.0166	0.148	CbGbCtD
Amoxapine—HTR2A—epilepsy syndrome	0.0165	0.0835	CbGaD
Amoxapine—GABRA1—Clobazam—epilepsy syndrome	0.016	0.142	CbGbCtD
Amoxapine—CYP2D6—epilepsy syndrome	0.0151	0.0763	CbGaD
Amoxapine—GABRA1—Amobarbital—epilepsy syndrome	0.0148	0.132	CbGbCtD
Amoxapine—GABRA1—Primidone—epilepsy syndrome	0.0123	0.11	CbGbCtD
Amoxapine—Cloxazolam—Clonazepam—epilepsy syndrome	0.0118	0.0481	CrCrCtD
Amoxapine—GABRA1—Propofol—epilepsy syndrome	0.0111	0.0986	CbGbCtD
Amoxapine—GABRA1—Phenobarbital—epilepsy syndrome	0.0106	0.0942	CbGbCtD
Amoxapine—GABRA1—Midazolam—epilepsy syndrome	0.0104	0.0929	CbGbCtD
Amoxapine—Cloxazolam—Diazepam—epilepsy syndrome	0.0101	0.0409	CrCrCtD
Amoxapine—GABRA1—Diazepam—epilepsy syndrome	0.01	0.0893	CbGbCtD
Amoxapine—Mazindol—Midazolam—epilepsy syndrome	0.00944	0.0384	CrCrCtD
Amoxapine—Mazindol—Diazepam—epilepsy syndrome	0.00841	0.0342	CrCrCtD
Amoxapine—GABRA1—Topiramate—epilepsy syndrome	0.00713	0.0635	CbGbCtD
Amoxapine—Chlordiazepoxide—Midazolam—epilepsy syndrome	0.00695	0.0283	CrCrCtD
Amoxapine—Chlordiazepoxide—Clobazam—epilepsy syndrome	0.00666	0.0271	CrCrCtD
Amoxapine—Estazolam—Clonazepam—epilepsy syndrome	0.00637	0.0259	CrCrCtD
Amoxapine—Oxazepam—Clonazepam—epilepsy syndrome	0.00637	0.0259	CrCrCtD
Amoxapine—Loxapine—Clobazam—epilepsy syndrome	0.00621	0.0253	CrCrCtD
Amoxapine—Chlordiazepoxide—Diazepam—epilepsy syndrome	0.00619	0.0252	CrCrCtD
Amoxapine—Estazolam—Midazolam—epilepsy syndrome	0.00608	0.0247	CrCrCtD
Amoxapine—Oxazepam—Midazolam—epilepsy syndrome	0.00608	0.0247	CrCrCtD
Amoxapine—Lorazepam—Clonazepam—epilepsy syndrome	0.00601	0.0244	CrCrCtD
Amoxapine—Clozapine—Clonazepam—epilepsy syndrome	0.00584	0.0238	CrCrCtD
Amoxapine—Estazolam—Clobazam—epilepsy syndrome	0.00583	0.0237	CrCrCtD
Amoxapine—Oxazepam—Clobazam—epilepsy syndrome	0.00583	0.0237	CrCrCtD
Amoxapine—Loxapine—Diazepam—epilepsy syndrome	0.00578	0.0235	CrCrCtD
Amoxapine—Lorazepam—Midazolam—epilepsy syndrome	0.00573	0.0233	CrCrCtD
Amoxapine—Temazepam—Midazolam—epilepsy syndrome	0.00557	0.0227	CrCrCtD
Amoxapine—Estazolam—Diazepam—epilepsy syndrome	0.00542	0.022	CrCrCtD
Amoxapine—Oxazepam—Diazepam—epilepsy syndrome	0.00542	0.022	CrCrCtD
Amoxapine—Prazepam—Clonazepam—epilepsy syndrome	0.0054	0.022	CrCrCtD
Amoxapine—Fludiazepam—Clonazepam—epilepsy syndrome	0.0054	0.022	CrCrCtD
Amoxapine—Temazepam—Clobazam—epilepsy syndrome	0.00534	0.0217	CrCrCtD
Amoxapine—Clozapine—Clobazam—epilepsy syndrome	0.00534	0.0217	CrCrCtD
Amoxapine—Fludiazepam—Midazolam—epilepsy syndrome	0.00515	0.0209	CrCrCtD
Amoxapine—Prazepam—Midazolam—epilepsy syndrome	0.00515	0.0209	CrCrCtD
Amoxapine—Delorazepam—Clonazepam—epilepsy syndrome	0.00514	0.0209	CrCrCtD
Amoxapine—Lorazepam—Diazepam—epilepsy syndrome	0.00511	0.0208	CrCrCtD
Amoxapine—Temazepam—Diazepam—epilepsy syndrome	0.00497	0.0202	CrCrCtD
Amoxapine—Clozapine—Diazepam—epilepsy syndrome	0.00497	0.0202	CrCrCtD
Amoxapine—Fludiazepam—Clobazam—epilepsy syndrome	0.00494	0.0201	CrCrCtD
Amoxapine—Prazepam—Clobazam—epilepsy syndrome	0.00494	0.0201	CrCrCtD
Amoxapine—Diazepam—Clonazepam—epilepsy syndrome	0.00491	0.02	CrCrCtD
Amoxapine—Delorazepam—Midazolam—epilepsy syndrome	0.0049	0.02	CrCrCtD
Amoxapine—Delorazepam—Clobazam—epilepsy syndrome	0.0047	0.0191	CrCrCtD
Amoxapine—Diazepam—Oxcarbazepine—epilepsy syndrome	0.00469	0.0191	CrCrCtD
Amoxapine—Diazepam—Midazolam—epilepsy syndrome	0.00469	0.0191	CrCrCtD
Amoxapine—Fludiazepam—Diazepam—epilepsy syndrome	0.00459	0.0187	CrCrCtD
Amoxapine—Prazepam—Diazepam—epilepsy syndrome	0.00459	0.0187	CrCrCtD
Amoxapine—Diazepam—Clobazam—epilepsy syndrome	0.00449	0.0183	CrCrCtD
Amoxapine—Delorazepam—Diazepam—epilepsy syndrome	0.00437	0.0178	CrCrCtD
Amoxapine—CYP2D6—Propofol—epilepsy syndrome	0.00323	0.0288	CbGbCtD
Amoxapine—HTR2A—phrenic nerve—epilepsy syndrome	0.00117	0.0371	CbGeAlD
Amoxapine—HTR3A—vagus nerve—epilepsy syndrome	0.000995	0.0315	CbGeAlD
Amoxapine—DRD3—telencephalic ventricle—epilepsy syndrome	0.000891	0.0282	CbGeAlD
Amoxapine—SLC6A2—locus ceruleus—epilepsy syndrome	0.000873	0.0276	CbGeAlD
Amoxapine—HTR7—locus ceruleus—epilepsy syndrome	0.000841	0.0266	CbGeAlD
Amoxapine—HTR7—vagus nerve—epilepsy syndrome	0.000644	0.0204	CbGeAlD
Amoxapine—DRD1—telencephalic ventricle—epilepsy syndrome	0.000638	0.0202	CbGeAlD
Amoxapine—HTR6—ganglion—epilepsy syndrome	0.000534	0.0169	CbGeAlD
Amoxapine—HTR2A—locus ceruleus—epilepsy syndrome	0.000524	0.0166	CbGeAlD
Amoxapine—HTR1B—telencephalic ventricle—epilepsy syndrome	0.000517	0.0163	CbGeAlD
Amoxapine—SLC6A3—telencephalic ventricle—epilepsy syndrome	0.000513	0.0162	CbGeAlD
Amoxapine—HTR2C—telencephalic ventricle—epilepsy syndrome	0.000496	0.0157	CbGeAlD
Amoxapine—HTR7—pons—epilepsy syndrome	0.000485	0.0153	CbGeAlD
Amoxapine—SLC6A2—autonomic nervous system—epilepsy syndrome	0.000464	0.0147	CbGeAlD
Amoxapine—HTR7—autonomic nervous system—epilepsy syndrome	0.000447	0.0141	CbGeAlD
Amoxapine—HTR2A—cerebellar cortex—epilepsy syndrome	0.000428	0.0135	CbGeAlD
Amoxapine—HTR1A—telencephalic ventricle—epilepsy syndrome	0.000417	0.0132	CbGeAlD
Amoxapine—HTR2A—vagus nerve—epilepsy syndrome	0.000402	0.0127	CbGeAlD
Amoxapine—HTR7—telencephalic ventricle—epilepsy syndrome	0.000399	0.0126	CbGeAlD
Amoxapine—DRD1—ganglion—epilepsy syndrome	0.000397	0.0126	CbGeAlD
Amoxapine—HTR3A—ganglion—epilepsy syndrome	0.000384	0.0121	CbGeAlD
Amoxapine—DRD2—telencephalic ventricle—epilepsy syndrome	0.000377	0.0119	CbGeAlD
Amoxapine—HTR1B—ganglion—epilepsy syndrome	0.000322	0.0102	CbGeAlD
Amoxapine—SLC6A3—ganglion—epilepsy syndrome	0.000319	0.0101	CbGeAlD
Amoxapine—HTR2C—ganglion—epilepsy syndrome	0.000309	0.00976	CbGeAlD
Amoxapine—HTR2A—pons—epilepsy syndrome	0.000302	0.00956	CbGeAlD
Amoxapine—SLC6A4—ganglion—epilepsy syndrome	0.000293	0.00925	CbGeAlD
Amoxapine—HTR2A—autonomic nervous system—epilepsy syndrome	0.000279	0.00881	CbGeAlD
Amoxapine—HTR1A—ganglion—epilepsy syndrome	0.00026	0.00821	CbGeAlD
Amoxapine—SLC6A2—ganglion—epilepsy syndrome	0.000258	0.00814	CbGeAlD
Amoxapine—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000249	0.00786	CbGeAlD
Amoxapine—HTR7—ganglion—epilepsy syndrome	0.000248	0.00785	CbGeAlD
Amoxapine—GABRA1—hindbrain—epilepsy syndrome	0.000244	0.00772	CbGeAlD
Amoxapine—SLC6A3—hindbrain—epilepsy syndrome	0.000242	0.00766	CbGeAlD
Amoxapine—DRD2—ganglion—epilepsy syndrome	0.000235	0.00742	CbGeAlD
Amoxapine—HTR6—forebrain—epilepsy syndrome	0.000224	0.00708	CbGeAlD
Amoxapine—SLC6A4—hindbrain—epilepsy syndrome	0.000222	0.00701	CbGeAlD
Amoxapine—HTR6—telencephalon—epilepsy syndrome	0.000206	0.00651	CbGeAlD
Amoxapine—HTR1A—hindbrain—epilepsy syndrome	0.000197	0.00623	CbGeAlD
Amoxapine—HTR7—hindbrain—epilepsy syndrome	0.000188	0.00595	CbGeAlD
Amoxapine—ADRA1A—hindbrain—epilepsy syndrome	0.000182	0.00574	CbGeAlD
Amoxapine—DRD2—hindbrain—epilepsy syndrome	0.000178	0.00563	CbGeAlD
Amoxapine—DRD1—brainstem—epilepsy syndrome	0.000173	0.00546	CbGeAlD
Amoxapine—HTR3A—brainstem—epilepsy syndrome	0.000167	0.00527	CbGeAlD
Amoxapine—DRD1—forebrain—epilepsy syndrome	0.000167	0.00527	CbGeAlD
Amoxapine—HTR3A—forebrain—epilepsy syndrome	0.000161	0.00509	CbGeAlD
Amoxapine—HTR2A—ganglion—epilepsy syndrome	0.000155	0.00489	CbGeAlD
Amoxapine—DRD1—telencephalon—epilepsy syndrome	0.000153	0.00485	CbGeAlD
Amoxapine—HTR3A—telencephalon—epilepsy syndrome	0.000148	0.00468	CbGeAlD
Amoxapine—HTR1B—brainstem—epilepsy syndrome	0.00014	0.00442	CbGeAlD
Amoxapine—GABRA1—brainstem—epilepsy syndrome	0.00014	0.00442	CbGeAlD
Amoxapine—SLC6A3—brainstem—epilepsy syndrome	0.000139	0.00439	CbGeAlD
Amoxapine—DRD4—brain—epilepsy syndrome	0.000137	0.00434	CbGeAlD
Amoxapine—HTR1B—forebrain—epilepsy syndrome	0.000135	0.00427	CbGeAlD
Amoxapine—GABRA1—forebrain—epilepsy syndrome	0.000135	0.00427	CbGeAlD
Amoxapine—HTR2C—brainstem—epilepsy syndrome	0.000134	0.00424	CbGeAlD
Amoxapine—SLC6A3—forebrain—epilepsy syndrome	0.000134	0.00423	CbGeAlD
Amoxapine—DRD3—head—epilepsy syndrome	0.000133	0.00421	CbGeAlD
Amoxapine—HTR2C—forebrain—epilepsy syndrome	0.000129	0.00409	CbGeAlD
Amoxapine—HTR6—head—epilepsy syndrome	0.000128	0.00406	CbGeAlD
Amoxapine—SLC6A4—brainstem—epilepsy syndrome	0.000127	0.00402	CbGeAlD
Amoxapine—DRD3—nervous system—epilepsy syndrome	0.000126	0.00399	CbGeAlD
Amoxapine—HTR1B—telencephalon—epilepsy syndrome	0.000124	0.00393	CbGeAlD
Amoxapine—GABRA1—telencephalon—epilepsy syndrome	0.000124	0.00393	CbGeAlD
Amoxapine—SLC6A3—telencephalon—epilepsy syndrome	0.000123	0.00389	CbGeAlD
Amoxapine—SLC6A4—forebrain—epilepsy syndrome	0.000123	0.00388	CbGeAlD
Amoxapine—CHRM1—forebrain—epilepsy syndrome	0.000122	0.00387	CbGeAlD
Amoxapine—DRD3—central nervous system—epilepsy syndrome	0.000122	0.00385	CbGeAlD
Amoxapine—HTR6—nervous system—epilepsy syndrome	0.000122	0.00385	CbGeAlD
Amoxapine—HTR2B—forebrain—epilepsy syndrome	0.000122	0.00385	CbGeAlD
Amoxapine—HTR2C—telencephalon—epilepsy syndrome	0.000119	0.00376	CbGeAlD
Amoxapine—HTR2A—hindbrain—epilepsy syndrome	0.000117	0.00371	CbGeAlD
Amoxapine—HTR6—central nervous system—epilepsy syndrome	0.000117	0.0037	CbGeAlD
Amoxapine—HTR1A—brainstem—epilepsy syndrome	0.000113	0.00357	CbGeAlD
Amoxapine—SLC6A4—telencephalon—epilepsy syndrome	0.000113	0.00357	CbGeAlD
Amoxapine—CHRM1—telencephalon—epilepsy syndrome	0.000112	0.00355	CbGeAlD
Amoxapine—SLC6A2—brainstem—epilepsy syndrome	0.000112	0.00354	CbGeAlD
Amoxapine—HTR2B—telencephalon—epilepsy syndrome	0.000112	0.00354	CbGeAlD
Amoxapine—DRD1—midbrain—epilepsy syndrome	0.00011	0.00348	CbGeAlD
Amoxapine—HTR1A—forebrain—epilepsy syndrome	0.000109	0.00345	CbGeAlD
Amoxapine—SLC6A2—forebrain—epilepsy syndrome	0.000108	0.00342	CbGeAlD
Amoxapine—HTR7—brainstem—epilepsy syndrome	0.000108	0.00341	CbGeAlD
Amoxapine—CYP2D6—hindbrain—epilepsy syndrome	0.000107	0.00338	CbGeAlD
Amoxapine—HTR7—forebrain—epilepsy syndrome	0.000104	0.00329	CbGeAlD
Amoxapine—ADRA1A—brainstem—epilepsy syndrome	0.000104	0.00329	CbGeAlD
Amoxapine—DRD2—brainstem—epilepsy syndrome	0.000102	0.00323	CbGeAlD
Amoxapine—ADRA1A—forebrain—epilepsy syndrome	0.0001	0.00318	CbGeAlD
Amoxapine—HTR1A—telencephalon—epilepsy syndrome	0.0001	0.00317	CbGeAlD
Amoxapine—SLC6A2—telencephalon—epilepsy syndrome	9.94e-05	0.00314	CbGeAlD
Amoxapine—DRD2—forebrain—epilepsy syndrome	9.85e-05	0.00311	CbGeAlD
Amoxapine—GABRA1—medulla oblongata—epilepsy syndrome	9.76e-05	0.00308	CbGeAlD
Amoxapine—DRD3—brain—epilepsy syndrome	9.66e-05	0.00305	CbGeAlD
Amoxapine—HTR7—telencephalon—epilepsy syndrome	9.58e-05	0.00303	CbGeAlD
Amoxapine—DRD1—head—epilepsy syndrome	9.54e-05	0.00302	CbGeAlD
Amoxapine—HTR2C—medulla oblongata—epilepsy syndrome	9.35e-05	0.00296	CbGeAlD
Amoxapine—HTR6—brain—epilepsy syndrome	9.3e-05	0.00294	CbGeAlD
Amoxapine—ORM1—spinal cord—epilepsy syndrome	9.28e-05	0.00293	CbGeAlD
Amoxapine—ADRA1A—telencephalon—epilepsy syndrome	9.24e-05	0.00292	CbGeAlD
Amoxapine—HTR3A—head—epilepsy syndrome	9.22e-05	0.00291	CbGeAlD
Amoxapine—DRD2—telencephalon—epilepsy syndrome	9.05e-05	0.00286	CbGeAlD
Amoxapine—DRD1—nervous system—epilepsy syndrome	9.05e-05	0.00286	CbGeAlD
Amoxapine—HTR1B—midbrain—epilepsy syndrome	8.92e-05	0.00282	CbGeAlD
Amoxapine—GABRA1—midbrain—epilepsy syndrome	8.92e-05	0.00282	CbGeAlD
Amoxapine—SLC6A3—midbrain—epilepsy syndrome	8.84e-05	0.0028	CbGeAlD
Amoxapine—HTR3A—nervous system—epilepsy syndrome	8.74e-05	0.00276	CbGeAlD
Amoxapine—DRD1—central nervous system—epilepsy syndrome	8.71e-05	0.00275	CbGeAlD
Amoxapine—HTR1B—spinal cord—epilepsy syndrome	8.7e-05	0.00275	CbGeAlD
Amoxapine—GABRA1—spinal cord—epilepsy syndrome	8.7e-05	0.00275	CbGeAlD
Amoxapine—SLC6A3—spinal cord—epilepsy syndrome	8.63e-05	0.00273	CbGeAlD
Amoxapine—HTR2C—midbrain—epilepsy syndrome	8.55e-05	0.0027	CbGeAlD
Amoxapine—HTR3A—central nervous system—epilepsy syndrome	8.41e-05	0.00266	CbGeAlD
Amoxapine—HTR2C—spinal cord—epilepsy syndrome	8.34e-05	0.00264	CbGeAlD
Amoxapine—SLC6A4—midbrain—epilepsy syndrome	8.1e-05	0.00256	CbGeAlD
Amoxapine—SLC6A4—spinal cord—epilepsy syndrome	7.91e-05	0.0025	CbGeAlD
Amoxapine—ORM1—nervous system—epilepsy syndrome	7.82e-05	0.00247	CbGeAlD
Amoxapine—SLC6A2—medulla oblongata—epilepsy syndrome	7.81e-05	0.00247	CbGeAlD
Amoxapine—HRH1—forebrain—epilepsy syndrome	7.78e-05	0.00246	CbGeAlD
Amoxapine—HTR1B—head—epilepsy syndrome	7.73e-05	0.00244	CbGeAlD
Amoxapine—GABRA1—head—epilepsy syndrome	7.73e-05	0.00244	CbGeAlD
Amoxapine—SLC6A3—head—epilepsy syndrome	7.67e-05	0.00242	CbGeAlD
Amoxapine—ADRA2A—forebrain—epilepsy syndrome	7.64e-05	0.00241	CbGeAlD
Amoxapine—ORM1—central nervous system—epilepsy syndrome	7.53e-05	0.00238	CbGeAlD
Amoxapine—HTR7—medulla oblongata—epilepsy syndrome	7.52e-05	0.00238	CbGeAlD
Amoxapine—HTR2C—head—epilepsy syndrome	7.41e-05	0.00234	CbGeAlD
Amoxapine—HTR1B—nervous system—epilepsy syndrome	7.33e-05	0.00232	CbGeAlD
Amoxapine—GABRA1—nervous system—epilepsy syndrome	7.33e-05	0.00232	CbGeAlD
Amoxapine—SLC6A3—nervous system—epilepsy syndrome	7.27e-05	0.0023	CbGeAlD
Amoxapine—HTR1A—midbrain—epilepsy syndrome	7.2e-05	0.00228	CbGeAlD
Amoxapine—HRH1—telencephalon—epilepsy syndrome	7.15e-05	0.00226	CbGeAlD
Amoxapine—HTR1B—central nervous system—epilepsy syndrome	7.06e-05	0.00223	CbGeAlD
Amoxapine—GABRA1—central nervous system—epilepsy syndrome	7.06e-05	0.00223	CbGeAlD
Amoxapine—HTR2C—nervous system—epilepsy syndrome	7.03e-05	0.00222	CbGeAlD
Amoxapine—SLC6A4—head—epilepsy syndrome	7.03e-05	0.00222	CbGeAlD
Amoxapine—ADRA2A—telencephalon—epilepsy syndrome	7.02e-05	0.00222	CbGeAlD
Amoxapine—HTR1A—spinal cord—epilepsy syndrome	7.02e-05	0.00222	CbGeAlD
Amoxapine—CHRM1—head—epilepsy syndrome	7e-05	0.00221	CbGeAlD
Amoxapine—SLC6A3—central nervous system—epilepsy syndrome	7e-05	0.00221	CbGeAlD
Amoxapine—HTR2B—head—epilepsy syndrome	6.96e-05	0.0022	CbGeAlD
Amoxapine—DRD1—brain—epilepsy syndrome	6.92e-05	0.00219	CbGeAlD
Amoxapine—GABRA1—cerebellum—epilepsy syndrome	6.9e-05	0.00218	CbGeAlD
Amoxapine—HTR7—midbrain—epilepsy syndrome	6.88e-05	0.00217	CbGeAlD
Amoxapine—SLC6A3—cerebellum—epilepsy syndrome	6.84e-05	0.00216	CbGeAlD
Amoxapine—HTR2C—central nervous system—epilepsy syndrome	6.77e-05	0.00214	CbGeAlD
Amoxapine—HTR2A—brainstem—epilepsy syndrome	6.73e-05	0.00213	CbGeAlD
Amoxapine—HTR7—spinal cord—epilepsy syndrome	6.71e-05	0.00212	CbGeAlD
Amoxapine—HTR3A—brain—epilepsy syndrome	6.68e-05	0.00211	CbGeAlD
Amoxapine—SLC6A4—nervous system—epilepsy syndrome	6.66e-05	0.00211	CbGeAlD
Amoxapine—CHRM1—nervous system—epilepsy syndrome	6.64e-05	0.0021	CbGeAlD
Amoxapine—HTR2B—nervous system—epilepsy syndrome	6.6e-05	0.00209	CbGeAlD
Amoxapine—DRD2—midbrain—epilepsy syndrome	6.5e-05	0.00206	CbGeAlD
Amoxapine—HTR2A—forebrain—epilepsy syndrome	6.49e-05	0.00205	CbGeAlD
Amoxapine—SLC6A4—central nervous system—epilepsy syndrome	6.41e-05	0.00203	CbGeAlD
Amoxapine—CHRM1—central nervous system—epilepsy syndrome	6.39e-05	0.00202	CbGeAlD
Amoxapine—HTR2B—central nervous system—epilepsy syndrome	6.36e-05	0.00201	CbGeAlD
Amoxapine—HTR1A—head—epilepsy syndrome	6.24e-05	0.00197	CbGeAlD
Amoxapine—SLC6A2—head—epilepsy syndrome	6.19e-05	0.00196	CbGeAlD
Amoxapine—CYP2D6—brainstem—epilepsy syndrome	6.13e-05	0.00194	CbGeAlD
Amoxapine—HTR2A—telencephalon—epilepsy syndrome	5.97e-05	0.00189	CbGeAlD
Amoxapine—HTR7—head—epilepsy syndrome	5.96e-05	0.00189	CbGeAlD
Amoxapine—CYP2D6—forebrain—epilepsy syndrome	5.92e-05	0.00187	CbGeAlD
Amoxapine—HTR1A—nervous system—epilepsy syndrome	5.92e-05	0.00187	CbGeAlD
Amoxapine—SLC6A2—nervous system—epilepsy syndrome	5.87e-05	0.00185	CbGeAlD
Amoxapine—Lorazepam—GABRG2—epilepsy syndrome	5.83e-05	0.0258	CrCbGaD
Amoxapine—ADRA1A—head—epilepsy syndrome	5.75e-05	0.00182	CbGeAlD
Amoxapine—HTR1A—central nervous system—epilepsy syndrome	5.7e-05	0.0018	CbGeAlD
Amoxapine—HTR7—nervous system—epilepsy syndrome	5.65e-05	0.00179	CbGeAlD
Amoxapine—SLC6A2—central nervous system—epilepsy syndrome	5.65e-05	0.00179	CbGeAlD
Amoxapine—DRD2—head—epilepsy syndrome	5.64e-05	0.00178	CbGeAlD
Amoxapine—HTR1B—brain—epilepsy syndrome	5.6e-05	0.00177	CbGeAlD
Amoxapine—GABRA1—brain—epilepsy syndrome	5.6e-05	0.00177	CbGeAlD
Amoxapine—HTR1A—cerebellum—epilepsy syndrome	5.57e-05	0.00176	CbGeAlD
Amoxapine—SLC6A3—brain—epilepsy syndrome	5.56e-05	0.00176	CbGeAlD
Amoxapine—ADRA2A—medulla oblongata—epilepsy syndrome	5.52e-05	0.00174	CbGeAlD
Amoxapine—ADRA1A—nervous system—epilepsy syndrome	5.45e-05	0.00172	CbGeAlD
Amoxapine—HTR7—central nervous system—epilepsy syndrome	5.44e-05	0.00172	CbGeAlD
Amoxapine—CYP2D6—telencephalon—epilepsy syndrome	5.44e-05	0.00172	CbGeAlD
Amoxapine—HTR2C—brain—epilepsy syndrome	5.37e-05	0.0017	CbGeAlD
Amoxapine—DRD2—nervous system—epilepsy syndrome	5.35e-05	0.00169	CbGeAlD
Amoxapine—HTR7—cerebellum—epilepsy syndrome	5.32e-05	0.00168	CbGeAlD
Amoxapine—ADRA1A—central nervous system—epilepsy syndrome	5.25e-05	0.00166	CbGeAlD
Amoxapine—DRD2—central nervous system—epilepsy syndrome	5.15e-05	0.00163	CbGeAlD
Amoxapine—ADRA1A—cerebellum—epilepsy syndrome	5.13e-05	0.00162	CbGeAlD
Amoxapine—SLC6A4—brain—epilepsy syndrome	5.09e-05	0.00161	CbGeAlD
Amoxapine—CHRM1—brain—epilepsy syndrome	5.07e-05	0.0016	CbGeAlD
Amoxapine—Chlordiazepoxide—GABRG2—epilepsy syndrome	5.07e-05	0.0224	CrCbGaD
Amoxapine—HTR2B—brain—epilepsy syndrome	5.05e-05	0.0016	CbGeAlD
Amoxapine—ADRA2A—midbrain—epilepsy syndrome	5.04e-05	0.00159	CbGeAlD
Amoxapine—DRD2—cerebellum—epilepsy syndrome	5.03e-05	0.00159	CbGeAlD
Amoxapine—ADRA2A—spinal cord—epilepsy syndrome	4.92e-05	0.00156	CbGeAlD
Amoxapine—Estazolam—GABRD—epilepsy syndrome	4.85e-05	0.0215	CrCbGaD
Amoxapine—HTR2A—medulla oblongata—epilepsy syndrome	4.69e-05	0.00148	CbGeAlD
Amoxapine—Lorazepam—GABRB3—epilepsy syndrome	4.69e-05	0.0208	CrCbGaD
Amoxapine—Fludiazepam—GABRD—epilepsy syndrome	4.58e-05	0.0203	CrCbGaD
Amoxapine—HTR1A—brain—epilepsy syndrome	4.52e-05	0.00143	CbGeAlD
Amoxapine—SLC6A2—brain—epilepsy syndrome	4.48e-05	0.00142	CbGeAlD
Amoxapine—Prazepam—GABRD—epilepsy syndrome	4.47e-05	0.0198	CrCbGaD
Amoxapine—Asenapine—HTR7—epilepsy syndrome	4.47e-05	0.0198	CrCbGaD
Amoxapine—HRH1—head—epilepsy syndrome	4.45e-05	0.00141	CbGeAlD
Amoxapine—ADRA2A—head—epilepsy syndrome	4.37e-05	0.00138	CbGeAlD
Amoxapine—HTR7—brain—epilepsy syndrome	4.32e-05	0.00137	CbGeAlD
Amoxapine—Desloratadine—CYP2C19—epilepsy syndrome	4.3e-05	0.019	CrCbGaD
Amoxapine—HTR2A—midbrain—epilepsy syndrome	4.29e-05	0.00136	CbGeAlD
Amoxapine—HRH1—nervous system—epilepsy syndrome	4.22e-05	0.00133	CbGeAlD
Amoxapine—HTR2A—spinal cord—epilepsy syndrome	4.18e-05	0.00132	CbGeAlD
Amoxapine—ADRA1A—brain—epilepsy syndrome	4.17e-05	0.00132	CbGeAlD
Amoxapine—ADRA2A—nervous system—epilepsy syndrome	4.15e-05	0.00131	CbGeAlD
Amoxapine—DRD2—brain—epilepsy syndrome	4.09e-05	0.00129	CbGeAlD
Amoxapine—Chlordiazepoxide—GABRB3—epilepsy syndrome	4.08e-05	0.0181	CrCbGaD
Amoxapine—Chlordiazepoxide—GABRA5—epilepsy syndrome	4.08e-05	0.0181	CrCbGaD
Amoxapine—HRH1—central nervous system—epilepsy syndrome	4.06e-05	0.00128	CbGeAlD
Amoxapine—Oxazepam—GABRD—epilepsy syndrome	4.03e-05	0.0179	CrCbGaD
Amoxapine—Lorazepam—GABRA1—epilepsy syndrome	4.03e-05	0.0178	CrCbGaD
Amoxapine—ADRA2A—central nervous system—epilepsy syndrome	3.99e-05	0.00126	CbGeAlD
Amoxapine—Temazepam—GABRD—epilepsy syndrome	3.98e-05	0.0176	CrCbGaD
Amoxapine—ADRA2A—cerebellum—epilepsy syndrome	3.9e-05	0.00123	CbGeAlD
Amoxapine—Asenapine—ADRA2A—epilepsy syndrome	3.83e-05	0.0169	CrCbGaD
Amoxapine—HTR2A—head—epilepsy syndrome	3.72e-05	0.00118	CbGeAlD
Amoxapine—Estazolam—GABRG2—epilepsy syndrome	3.68e-05	0.0163	CrCbGaD
Amoxapine—Chlordiazepoxide—GABRB2—epilepsy syndrome	3.57e-05	0.0158	CrCbGaD
Amoxapine—HTR2A—nervous system—epilepsy syndrome	3.53e-05	0.00111	CbGeAlD
Amoxapine—Chlordiazepoxide—GABRA1—epilepsy syndrome	3.51e-05	0.0155	CrCbGaD
Amoxapine—Fludiazepam—GABRG2—epilepsy syndrome	3.47e-05	0.0153	CrCbGaD
Amoxapine—HTR2A—central nervous system—epilepsy syndrome	3.39e-05	0.00107	CbGeAlD
Amoxapine—CYP2D6—head—epilepsy syndrome	3.39e-05	0.00107	CbGeAlD
Amoxapine—Prazepam—GABRG2—epilepsy syndrome	3.39e-05	0.015	CrCbGaD
Amoxapine—HTR2A—cerebellum—epilepsy syndrome	3.32e-05	0.00105	CbGeAlD
Amoxapine—Diazepam—GABRD—epilepsy syndrome	3.31e-05	0.0146	CrCbGaD
Amoxapine—Olanzapine—CHRM3—epilepsy syndrome	3.28e-05	0.0145	CrCbGaD
Amoxapine—HRH1—brain—epilepsy syndrome	3.23e-05	0.00102	CbGeAlD
Amoxapine—CYP2D6—nervous system—epilepsy syndrome	3.21e-05	0.00102	CbGeAlD
Amoxapine—Desloratadine—CYP2D6—epilepsy syndrome	3.19e-05	0.0141	CrCbGaD
Amoxapine—ADRA2A—brain—epilepsy syndrome	3.17e-05	0.001	CbGeAlD
Amoxapine—CYP2D6—central nervous system—epilepsy syndrome	3.09e-05	0.000978	CbGeAlD
Amoxapine—Oxazepam—GABRG2—epilepsy syndrome	3.06e-05	0.0135	CrCbGaD
Amoxapine—Olanzapine—CHRM1—epilepsy syndrome	3.06e-05	0.0135	CrCbGaD
Amoxapine—CYP2D6—cerebellum—epilepsy syndrome	3.02e-05	0.000956	CbGeAlD
Amoxapine—Temazepam—GABRG2—epilepsy syndrome	3.02e-05	0.0134	CrCbGaD
Amoxapine—Estazolam—GABRB3—epilepsy syndrome	2.96e-05	0.0131	CrCbGaD
Amoxapine—Estazolam—GABRA5—epilepsy syndrome	2.96e-05	0.0131	CrCbGaD
Amoxapine—Asenapine—SLC6A4—epilepsy syndrome	2.92e-05	0.0129	CrCbGaD
Amoxapine—Clozapine—HRH3—epilepsy syndrome	2.86e-05	0.0126	CrCbGaD
Amoxapine—Dermatitis—Midazolam—epilepsy syndrome	2.81e-05	0.000406	CcSEcCtD
Amoxapine—Urticaria—Carbamazepine—epilepsy syndrome	2.81e-05	0.000406	CcSEcCtD
Amoxapine—Mazindol—SLC6A4—epilepsy syndrome	2.8e-05	0.0124	CrCbGaD
Amoxapine—Vomiting—Levetiracetam—epilepsy syndrome	2.8e-05	0.000405	CcSEcCtD
Amoxapine—Alopecia—Gabapentin—epilepsy syndrome	2.8e-05	0.000404	CcSEcCtD
Amoxapine—Headache—Midazolam—epilepsy syndrome	2.8e-05	0.000404	CcSEcCtD
Amoxapine—Pruritus—Felbamate—epilepsy syndrome	2.79e-05	0.000404	CcSEcCtD
Amoxapine—Body temperature increased—Carbamazepine—epilepsy syndrome	2.79e-05	0.000404	CcSEcCtD
Amoxapine—Abdominal pain—Carbamazepine—epilepsy syndrome	2.79e-05	0.000404	CcSEcCtD
Amoxapine—Fludiazepam—GABRA5—epilepsy syndrome	2.79e-05	0.0124	CrCbGaD
Amoxapine—Fludiazepam—GABRB3—epilepsy syndrome	2.79e-05	0.0124	CrCbGaD
Amoxapine—Diarrhoea—Diazepam—epilepsy syndrome	2.79e-05	0.000404	CcSEcCtD
Amoxapine—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	2.79e-05	0.000404	CcSEcCtD
Amoxapine—Rash—Levetiracetam—epilepsy syndrome	2.78e-05	0.000402	CcSEcCtD
Amoxapine—Dermatitis—Levetiracetam—epilepsy syndrome	2.78e-05	0.000401	CcSEcCtD
Amoxapine—Asthenia—Zonisamide—epilepsy syndrome	2.77e-05	0.000401	CcSEcCtD
Amoxapine—Agranulocytosis—Topiramate—epilepsy syndrome	2.77e-05	0.0004	CcSEcCtD
Amoxapine—Dry mouth—Valproic Acid—epilepsy syndrome	2.77e-05	0.0004	CcSEcCtD
Amoxapine—Agitation—Pregabalin—epilepsy syndrome	2.76e-05	0.000399	CcSEcCtD
Amoxapine—Headache—Levetiracetam—epilepsy syndrome	2.76e-05	0.000399	CcSEcCtD
Amoxapine—Dizziness—Vigabatrin—epilepsy syndrome	2.74e-05	0.000396	CcSEcCtD
Amoxapine—Confusional state—Valproic Acid—epilepsy syndrome	2.74e-05	0.000395	CcSEcCtD
Amoxapine—Pruritus—Zonisamide—epilepsy syndrome	2.74e-05	0.000395	CcSEcCtD
Amoxapine—Prazepam—GABRB3—epilepsy syndrome	2.73e-05	0.0121	CrCbGaD
Amoxapine—Prazepam—GABRA5—epilepsy syndrome	2.73e-05	0.0121	CrCbGaD
Amoxapine—Flatulence—Gabapentin—epilepsy syndrome	2.72e-05	0.000393	CcSEcCtD
Amoxapine—Oedema—Valproic Acid—epilepsy syndrome	2.71e-05	0.000392	CcSEcCtD
Amoxapine—Urticaria—Lamotrigine—epilepsy syndrome	2.71e-05	0.000392	CcSEcCtD
Amoxapine—Nausea—Propofol—epilepsy syndrome	2.71e-05	0.000392	CcSEcCtD
Amoxapine—Tension—Gabapentin—epilepsy syndrome	2.7e-05	0.000391	CcSEcCtD
Amoxapine—Vomiting—Fosphenytoin—epilepsy syndrome	2.7e-05	0.000391	CcSEcCtD
Amoxapine—Diarrhoea—Felbamate—epilepsy syndrome	2.7e-05	0.000391	CcSEcCtD
Amoxapine—Body temperature increased—Lamotrigine—epilepsy syndrome	2.7e-05	0.00039	CcSEcCtD
Amoxapine—Abdominal pain—Lamotrigine—epilepsy syndrome	2.7e-05	0.00039	CcSEcCtD
Amoxapine—Dysgeusia—Gabapentin—epilepsy syndrome	2.7e-05	0.00039	CcSEcCtD
Amoxapine—Dizziness—Diazepam—epilepsy syndrome	2.7e-05	0.00039	CcSEcCtD
Amoxapine—Syncope—Pregabalin—epilepsy syndrome	2.7e-05	0.00039	CcSEcCtD
Amoxapine—HTR2A—brain—epilepsy syndrome	2.69e-05	0.000852	CbGeAlD
Amoxapine—Leukopenia—Pregabalin—epilepsy syndrome	2.69e-05	0.000389	CcSEcCtD
Amoxapine—Rash—Fosphenytoin—epilepsy syndrome	2.68e-05	0.000388	CcSEcCtD
Amoxapine—Dermatitis—Fosphenytoin—epilepsy syndrome	2.68e-05	0.000387	CcSEcCtD
Amoxapine—Nervousness—Gabapentin—epilepsy syndrome	2.68e-05	0.000387	CcSEcCtD
Amoxapine—Asthenia—Clonazepam—epilepsy syndrome	2.67e-05	0.000386	CcSEcCtD
Amoxapine—Headache—Fosphenytoin—epilepsy syndrome	2.66e-05	0.000385	CcSEcCtD
Amoxapine—Hepatitis—Topiramate—epilepsy syndrome	2.66e-05	0.000385	CcSEcCtD
Amoxapine—Thrombocytopenia—Valproic Acid—epilepsy syndrome	2.66e-05	0.000384	CcSEcCtD
Amoxapine—Palpitations—Pregabalin—epilepsy syndrome	2.66e-05	0.000384	CcSEcCtD
Amoxapine—Asthenia—Phenytoin—epilepsy syndrome	2.66e-05	0.000384	CcSEcCtD
Amoxapine—Nausea—Midazolam—epilepsy syndrome	2.65e-05	0.000383	CcSEcCtD
Amoxapine—Hallucination—Topiramate—epilepsy syndrome	2.65e-05	0.000383	CcSEcCtD
Amoxapine—Hypoaesthesia—Topiramate—epilepsy syndrome	2.65e-05	0.000383	CcSEcCtD
Amoxapine—Tachycardia—Valproic Acid—epilepsy syndrome	2.65e-05	0.000383	CcSEcCtD
Amoxapine—Diarrhoea—Zonisamide—epilepsy syndrome	2.65e-05	0.000382	CcSEcCtD
Amoxapine—Loss of consciousness—Pregabalin—epilepsy syndrome	2.64e-05	0.000382	CcSEcCtD
Amoxapine—Asthenia—Oxcarbazepine—epilepsy syndrome	2.64e-05	0.000382	CcSEcCtD
Amoxapine—Pruritus—Clonazepam—epilepsy syndrome	2.64e-05	0.000381	CcSEcCtD
Amoxapine—Vomiting—Vigabatrin—epilepsy syndrome	2.64e-05	0.000381	CcSEcCtD
Amoxapine—Pruritus—Phenytoin—epilepsy syndrome	2.62e-05	0.000379	CcSEcCtD
Amoxapine—Nausea—Levetiracetam—epilepsy syndrome	2.62e-05	0.000378	CcSEcCtD
Amoxapine—Rash—Vigabatrin—epilepsy syndrome	2.61e-05	0.000378	CcSEcCtD
Amoxapine—Dizziness—Felbamate—epilepsy syndrome	2.61e-05	0.000378	CcSEcCtD
Amoxapine—Dermatitis—Vigabatrin—epilepsy syndrome	2.61e-05	0.000377	CcSEcCtD
Amoxapine—Pruritus—Oxcarbazepine—epilepsy syndrome	2.6e-05	0.000377	CcSEcCtD
Amoxapine—Convulsion—Pregabalin—epilepsy syndrome	2.6e-05	0.000376	CcSEcCtD
Amoxapine—Vision blurred—Gabapentin—epilepsy syndrome	2.6e-05	0.000375	CcSEcCtD
Amoxapine—Headache—Vigabatrin—epilepsy syndrome	2.6e-05	0.000375	CcSEcCtD
Amoxapine—Hypertension—Pregabalin—epilepsy syndrome	2.59e-05	0.000375	CcSEcCtD
Amoxapine—Vomiting—Diazepam—epilepsy syndrome	2.59e-05	0.000375	CcSEcCtD
Amoxapine—Estazolam—GABRB2—epilepsy syndrome	2.59e-05	0.0115	CrCbGaD
Amoxapine—Anorexia—Valproic Acid—epilepsy syndrome	2.59e-05	0.000374	CcSEcCtD
Amoxapine—Tremor—Gabapentin—epilepsy syndrome	2.58e-05	0.000373	CcSEcCtD
Amoxapine—Rash—Diazepam—epilepsy syndrome	2.57e-05	0.000372	CcSEcCtD
Amoxapine—Dermatitis—Diazepam—epilepsy syndrome	2.57e-05	0.000372	CcSEcCtD
Amoxapine—Dizziness—Zonisamide—epilepsy syndrome	2.56e-05	0.00037	CcSEcCtD
Amoxapine—Headache—Diazepam—epilepsy syndrome	2.56e-05	0.00037	CcSEcCtD
Amoxapine—Diarrhoea—Clonazepam—epilepsy syndrome	2.55e-05	0.000369	CcSEcCtD
Amoxapine—Estazolam—GABRA1—epilepsy syndrome	2.54e-05	0.0112	CrCbGaD
Amoxapine—Hypotension—Valproic Acid—epilepsy syndrome	2.54e-05	0.000367	CcSEcCtD
Amoxapine—Asthenia—Carbamazepine—epilepsy syndrome	2.53e-05	0.000366	CcSEcCtD
Amoxapine—Agitation—Gabapentin—epilepsy syndrome	2.53e-05	0.000366	CcSEcCtD
Amoxapine—Diarrhoea—Phenytoin—epilepsy syndrome	2.53e-05	0.000366	CcSEcCtD
Amoxapine—Nausea—Fosphenytoin—epilepsy syndrome	2.53e-05	0.000365	CcSEcCtD
Amoxapine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.52e-05	0.000364	CcSEcCtD
Amoxapine—Vomiting—Felbamate—epilepsy syndrome	2.51e-05	0.000363	CcSEcCtD
Amoxapine—Diazepam—GABRG2—epilepsy syndrome	2.51e-05	0.0111	CrCbGaD
Amoxapine—Dry mouth—Pregabalin—epilepsy syndrome	2.5e-05	0.000362	CcSEcCtD
Amoxapine—Pruritus—Carbamazepine—epilepsy syndrome	2.5e-05	0.000361	CcSEcCtD
Amoxapine—Olanzapine—CHRM2—epilepsy syndrome	2.5e-05	0.011	CrCbGaD
Amoxapine—Rash—Felbamate—epilepsy syndrome	2.49e-05	0.00036	CcSEcCtD
Amoxapine—Dermatitis—Felbamate—epilepsy syndrome	2.49e-05	0.00036	CcSEcCtD
Amoxapine—Olanzapine—HTR7—epilepsy syndrome	2.48e-05	0.011	CrCbGaD
Amoxapine—Tinnitus—Topiramate—epilepsy syndrome	2.48e-05	0.000359	CcSEcCtD
Amoxapine—Headache—Felbamate—epilepsy syndrome	2.47e-05	0.000358	CcSEcCtD
Amoxapine—Confusional state—Pregabalin—epilepsy syndrome	2.47e-05	0.000358	CcSEcCtD
Amoxapine—Syncope—Gabapentin—epilepsy syndrome	2.47e-05	0.000357	CcSEcCtD
Amoxapine—Leukopenia—Gabapentin—epilepsy syndrome	2.47e-05	0.000357	CcSEcCtD
Amoxapine—Dizziness—Clonazepam—epilepsy syndrome	2.46e-05	0.000356	CcSEcCtD
Amoxapine—Nausea—Vigabatrin—epilepsy syndrome	2.46e-05	0.000356	CcSEcCtD
Amoxapine—Oxazepam—GABRB3—epilepsy syndrome	2.46e-05	0.0109	CrCbGaD
Amoxapine—Oxazepam—GABRA5—epilepsy syndrome	2.46e-05	0.0109	CrCbGaD
Amoxapine—Vomiting—Zonisamide—epilepsy syndrome	2.46e-05	0.000355	CcSEcCtD
Amoxapine—CYP2D6—brain—epilepsy syndrome	2.46e-05	0.000776	CbGeAlD
Amoxapine—Insomnia—Valproic Acid—epilepsy syndrome	2.45e-05	0.000355	CcSEcCtD
Amoxapine—Oedema—Pregabalin—epilepsy syndrome	2.45e-05	0.000355	CcSEcCtD
Amoxapine—Asthenia—Lamotrigine—epilepsy syndrome	2.45e-05	0.000354	CcSEcCtD
Amoxapine—Dizziness—Phenytoin—epilepsy syndrome	2.45e-05	0.000354	CcSEcCtD
Amoxapine—Fludiazepam—GABRB2—epilepsy syndrome	2.44e-05	0.0108	CrCbGaD
Amoxapine—Rash—Zonisamide—epilepsy syndrome	2.44e-05	0.000352	CcSEcCtD
Amoxapine—Paraesthesia—Valproic Acid—epilepsy syndrome	2.44e-05	0.000352	CcSEcCtD
Amoxapine—Palpitations—Gabapentin—epilepsy syndrome	2.44e-05	0.000352	CcSEcCtD
Amoxapine—Dermatitis—Zonisamide—epilepsy syndrome	2.44e-05	0.000352	CcSEcCtD
Amoxapine—Dizziness—Oxcarbazepine—epilepsy syndrome	2.43e-05	0.000352	CcSEcCtD
Amoxapine—Temazepam—GABRA5—epilepsy syndrome	2.43e-05	0.0108	CrCbGaD
Amoxapine—Temazepam—GABRB3—epilepsy syndrome	2.43e-05	0.0108	CrCbGaD
Amoxapine—Nausea—Diazepam—epilepsy syndrome	2.42e-05	0.00035	CcSEcCtD
Amoxapine—Loss of consciousness—Gabapentin—epilepsy syndrome	2.42e-05	0.00035	CcSEcCtD
Amoxapine—Headache—Zonisamide—epilepsy syndrome	2.42e-05	0.00035	CcSEcCtD
Amoxapine—Diarrhoea—Carbamazepine—epilepsy syndrome	2.42e-05	0.000349	CcSEcCtD
Amoxapine—Pruritus—Lamotrigine—epilepsy syndrome	2.42e-05	0.000349	CcSEcCtD
Amoxapine—Shock—Pregabalin—epilepsy syndrome	2.41e-05	0.000349	CcSEcCtD
Amoxapine—Somnolence—Valproic Acid—epilepsy syndrome	2.41e-05	0.000349	CcSEcCtD
Amoxapine—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.4e-05	0.000347	CcSEcCtD
Amoxapine—Fludiazepam—GABRA1—epilepsy syndrome	2.4e-05	0.0106	CrCbGaD
Amoxapine—Tachycardia—Pregabalin—epilepsy syndrome	2.39e-05	0.000346	CcSEcCtD
Amoxapine—Dyspepsia—Valproic Acid—epilepsy syndrome	2.39e-05	0.000345	CcSEcCtD
Amoxapine—Convulsion—Gabapentin—epilepsy syndrome	2.39e-05	0.000345	CcSEcCtD
Amoxapine—Prazepam—GABRB2—epilepsy syndrome	2.39e-05	0.0106	CrCbGaD
Amoxapine—Hypertension—Gabapentin—epilepsy syndrome	2.38e-05	0.000344	CcSEcCtD
Amoxapine—Vomiting—Clonazepam—epilepsy syndrome	2.37e-05	0.000342	CcSEcCtD
Amoxapine—Decreased appetite—Valproic Acid—epilepsy syndrome	2.36e-05	0.000341	CcSEcCtD
Amoxapine—Alopecia—Topiramate—epilepsy syndrome	2.35e-05	0.00034	CcSEcCtD
Amoxapine—Vomiting—Phenytoin—epilepsy syndrome	2.35e-05	0.00034	CcSEcCtD
Amoxapine—Rash—Clonazepam—epilepsy syndrome	2.35e-05	0.00034	CcSEcCtD
Amoxapine—Dermatitis—Clonazepam—epilepsy syndrome	2.35e-05	0.000339	CcSEcCtD
Amoxapine—Nausea—Felbamate—epilepsy syndrome	2.35e-05	0.000339	CcSEcCtD
Amoxapine—Vomiting—Oxcarbazepine—epilepsy syndrome	2.34e-05	0.000338	CcSEcCtD
Amoxapine—Prazepam—GABRA1—epilepsy syndrome	2.34e-05	0.0104	CrCbGaD
Amoxapine—Fatigue—Valproic Acid—epilepsy syndrome	2.34e-05	0.000338	CcSEcCtD
Amoxapine—Anorexia—Pregabalin—epilepsy syndrome	2.34e-05	0.000338	CcSEcCtD
Amoxapine—Dizziness—Carbamazepine—epilepsy syndrome	2.34e-05	0.000338	CcSEcCtD
Amoxapine—Diarrhoea—Lamotrigine—epilepsy syndrome	2.34e-05	0.000338	CcSEcCtD
Amoxapine—Headache—Clonazepam—epilepsy syndrome	2.33e-05	0.000337	CcSEcCtD
Amoxapine—Rash—Phenytoin—epilepsy syndrome	2.33e-05	0.000337	CcSEcCtD
Amoxapine—Dermatitis—Phenytoin—epilepsy syndrome	2.33e-05	0.000337	CcSEcCtD
Amoxapine—Rash—Oxcarbazepine—epilepsy syndrome	2.32e-05	0.000336	CcSEcCtD
Amoxapine—Constipation—Valproic Acid—epilepsy syndrome	2.32e-05	0.000335	CcSEcCtD
Amoxapine—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.32e-05	0.000335	CcSEcCtD
Amoxapine—Headache—Phenytoin—epilepsy syndrome	2.32e-05	0.000335	CcSEcCtD
Amoxapine—Headache—Oxcarbazepine—epilepsy syndrome	2.31e-05	0.000333	CcSEcCtD
Amoxapine—Nausea—Zonisamide—epilepsy syndrome	2.3e-05	0.000332	CcSEcCtD
Amoxapine—Dry mouth—Gabapentin—epilepsy syndrome	2.29e-05	0.000332	CcSEcCtD
Amoxapine—Hypotension—Pregabalin—epilepsy syndrome	2.29e-05	0.000331	CcSEcCtD
Amoxapine—Flatulence—Topiramate—epilepsy syndrome	2.28e-05	0.00033	CcSEcCtD
Amoxapine—Desloratadine—ABCB1—epilepsy syndrome	2.28e-05	0.0101	CrCbGaD
Amoxapine—Tension—Topiramate—epilepsy syndrome	2.28e-05	0.000329	CcSEcCtD
Amoxapine—Dysgeusia—Topiramate—epilepsy syndrome	2.27e-05	0.000328	CcSEcCtD
Amoxapine—Confusional state—Gabapentin—epilepsy syndrome	2.27e-05	0.000328	CcSEcCtD
Amoxapine—Dizziness—Lamotrigine—epilepsy syndrome	2.26e-05	0.000326	CcSEcCtD
Amoxapine—Nervousness—Topiramate—epilepsy syndrome	2.25e-05	0.000326	CcSEcCtD
Amoxapine—Oedema—Gabapentin—epilepsy syndrome	2.25e-05	0.000325	CcSEcCtD
Amoxapine—Vomiting—Carbamazepine—epilepsy syndrome	2.25e-05	0.000325	CcSEcCtD
Amoxapine—Asenapine—HTR2A—epilepsy syndrome	2.25e-05	0.00994	CrCbGaD
Amoxapine—Zuclopenthixol—ADRA2A—epilepsy syndrome	2.24e-05	0.0099	CrCbGaD
Amoxapine—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.24e-05	0.000323	CcSEcCtD
Amoxapine—Rash—Carbamazepine—epilepsy syndrome	2.23e-05	0.000322	CcSEcCtD
Amoxapine—Dermatitis—Carbamazepine—epilepsy syndrome	2.23e-05	0.000322	CcSEcCtD
Amoxapine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.22e-05	0.000321	CcSEcCtD
Amoxapine—Insomnia—Pregabalin—epilepsy syndrome	2.22e-05	0.000321	CcSEcCtD
Amoxapine—Nausea—Clonazepam—epilepsy syndrome	2.21e-05	0.00032	CcSEcCtD
Amoxapine—Headache—Carbamazepine—epilepsy syndrome	2.21e-05	0.00032	CcSEcCtD
Amoxapine—Shock—Gabapentin—epilepsy syndrome	2.21e-05	0.00032	CcSEcCtD
Amoxapine—Paraesthesia—Pregabalin—epilepsy syndrome	2.2e-05	0.000318	CcSEcCtD
Amoxapine—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.2e-05	0.000318	CcSEcCtD
Amoxapine—Nausea—Phenytoin—epilepsy syndrome	2.2e-05	0.000318	CcSEcCtD
Amoxapine—Tachycardia—Gabapentin—epilepsy syndrome	2.2e-05	0.000317	CcSEcCtD
Amoxapine—Nausea—Oxcarbazepine—epilepsy syndrome	2.19e-05	0.000316	CcSEcCtD
Amoxapine—Vision blurred—Topiramate—epilepsy syndrome	2.19e-05	0.000316	CcSEcCtD
Amoxapine—Somnolence—Pregabalin—epilepsy syndrome	2.18e-05	0.000315	CcSEcCtD
Amoxapine—Tremor—Topiramate—epilepsy syndrome	2.17e-05	0.000314	CcSEcCtD
Amoxapine—Vomiting—Lamotrigine—epilepsy syndrome	2.17e-05	0.000314	CcSEcCtD
Amoxapine—Urticaria—Valproic Acid—epilepsy syndrome	2.16e-05	0.000312	CcSEcCtD
Amoxapine—Oxazepam—GABRB2—epilepsy syndrome	2.15e-05	0.00953	CrCbGaD
Amoxapine—Rash—Lamotrigine—epilepsy syndrome	2.15e-05	0.000311	CcSEcCtD
Amoxapine—Dermatitis—Lamotrigine—epilepsy syndrome	2.15e-05	0.000311	CcSEcCtD
Amoxapine—Body temperature increased—Valproic Acid—epilepsy syndrome	2.14e-05	0.00031	CcSEcCtD
Amoxapine—Abdominal pain—Valproic Acid—epilepsy syndrome	2.14e-05	0.00031	CcSEcCtD
Amoxapine—Anorexia—Gabapentin—epilepsy syndrome	2.14e-05	0.00031	CcSEcCtD
Amoxapine—Headache—Lamotrigine—epilepsy syndrome	2.14e-05	0.000309	CcSEcCtD
Amoxapine—Decreased appetite—Pregabalin—epilepsy syndrome	2.13e-05	0.000308	CcSEcCtD
Amoxapine—Olanzapine—ADRA2A—epilepsy syndrome	2.13e-05	0.00943	CrCbGaD
Amoxapine—Agitation—Topiramate—epilepsy syndrome	2.13e-05	0.000308	CcSEcCtD
Amoxapine—Temazepam—GABRB2—epilepsy syndrome	2.13e-05	0.00941	CrCbGaD
Amoxapine—Fatigue—Pregabalin—epilepsy syndrome	2.11e-05	0.000306	CcSEcCtD
Amoxapine—Oxazepam—GABRA1—epilepsy syndrome	2.11e-05	0.00935	CrCbGaD
Amoxapine—Hypotension—Gabapentin—epilepsy syndrome	2.1e-05	0.000304	CcSEcCtD
Amoxapine—Nausea—Carbamazepine—epilepsy syndrome	2.1e-05	0.000303	CcSEcCtD
Amoxapine—Constipation—Pregabalin—epilepsy syndrome	2.1e-05	0.000303	CcSEcCtD
Amoxapine—Temazepam—GABRA1—epilepsy syndrome	2.09e-05	0.00923	CrCbGaD
Amoxapine—Syncope—Topiramate—epilepsy syndrome	2.08e-05	0.000301	CcSEcCtD
Amoxapine—Leukopenia—Topiramate—epilepsy syndrome	2.08e-05	0.0003	CcSEcCtD
Amoxapine—Asenapine—CYP2D6—epilepsy syndrome	2.05e-05	0.00909	CrCbGaD
Amoxapine—Palpitations—Topiramate—epilepsy syndrome	2.05e-05	0.000296	CcSEcCtD
Amoxapine—Loxapine—CHRM3—epilepsy syndrome	2.04e-05	0.00902	CrCbGaD
Amoxapine—Loss of consciousness—Topiramate—epilepsy syndrome	2.04e-05	0.000295	CcSEcCtD
Amoxapine—Insomnia—Gabapentin—epilepsy syndrome	2.03e-05	0.000294	CcSEcCtD
Amoxapine—Nausea—Lamotrigine—epilepsy syndrome	2.03e-05	0.000293	CcSEcCtD
Amoxapine—Feeling abnormal—Pregabalin—epilepsy syndrome	2.02e-05	0.000292	CcSEcCtD
Amoxapine—Paraesthesia—Gabapentin—epilepsy syndrome	2.02e-05	0.000292	CcSEcCtD
Amoxapine—Diazepam—GABRA5—epilepsy syndrome	2.02e-05	0.00893	CrCbGaD
Amoxapine—Diazepam—GABRB3—epilepsy syndrome	2.02e-05	0.00893	CrCbGaD
Amoxapine—Convulsion—Topiramate—epilepsy syndrome	2.01e-05	0.00029	CcSEcCtD
Amoxapine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.01e-05	0.00029	CcSEcCtD
Amoxapine—Hypertension—Topiramate—epilepsy syndrome	2e-05	0.000289	CcSEcCtD
Amoxapine—Somnolence—Gabapentin—epilepsy syndrome	2e-05	0.000289	CcSEcCtD
Amoxapine—Quetiapine—CHRM3—epilepsy syndrome	1.99e-05	0.0088	CrCbGaD
Amoxapine—Dyspepsia—Gabapentin—epilepsy syndrome	1.98e-05	0.000286	CcSEcCtD
Amoxapine—Decreased appetite—Gabapentin—epilepsy syndrome	1.96e-05	0.000283	CcSEcCtD
Amoxapine—Urticaria—Pregabalin—epilepsy syndrome	1.95e-05	0.000282	CcSEcCtD
Amoxapine—Asthenia—Valproic Acid—epilepsy syndrome	1.95e-05	0.000281	CcSEcCtD
Amoxapine—Fatigue—Gabapentin—epilepsy syndrome	1.94e-05	0.00028	CcSEcCtD
Amoxapine—Abdominal pain—Pregabalin—epilepsy syndrome	1.94e-05	0.00028	CcSEcCtD
Amoxapine—Body temperature increased—Pregabalin—epilepsy syndrome	1.94e-05	0.00028	CcSEcCtD
Amoxapine—Dry mouth—Topiramate—epilepsy syndrome	1.93e-05	0.000279	CcSEcCtD
Amoxapine—Constipation—Gabapentin—epilepsy syndrome	1.92e-05	0.000278	CcSEcCtD
Amoxapine—Pruritus—Valproic Acid—epilepsy syndrome	1.92e-05	0.000277	CcSEcCtD
Amoxapine—Confusional state—Topiramate—epilepsy syndrome	1.91e-05	0.000276	CcSEcCtD
Amoxapine—Loxapine—CHRM1—epilepsy syndrome	1.9e-05	0.00841	CrCbGaD
Amoxapine—Oedema—Topiramate—epilepsy syndrome	1.89e-05	0.000274	CcSEcCtD
Amoxapine—Shock—Topiramate—epilepsy syndrome	1.86e-05	0.000269	CcSEcCtD
Amoxapine—Diarrhoea—Valproic Acid—epilepsy syndrome	1.86e-05	0.000268	CcSEcCtD
Amoxapine—Quetiapine—CHRM1—epilepsy syndrome	1.86e-05	0.00821	CrCbGaD
Amoxapine—Feeling abnormal—Gabapentin—epilepsy syndrome	1.85e-05	0.000268	CcSEcCtD
Amoxapine—Thrombocytopenia—Topiramate—epilepsy syndrome	1.85e-05	0.000268	CcSEcCtD
Amoxapine—Tachycardia—Topiramate—epilepsy syndrome	1.85e-05	0.000267	CcSEcCtD
Amoxapine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.84e-05	0.000266	CcSEcCtD
Amoxapine—Anorexia—Topiramate—epilepsy syndrome	1.8e-05	0.000261	CcSEcCtD
Amoxapine—Dizziness—Valproic Acid—epilepsy syndrome	1.79e-05	0.000259	CcSEcCtD
Amoxapine—Urticaria—Gabapentin—epilepsy syndrome	1.79e-05	0.000258	CcSEcCtD
Amoxapine—Abdominal pain—Gabapentin—epilepsy syndrome	1.78e-05	0.000257	CcSEcCtD
Amoxapine—Body temperature increased—Gabapentin—epilepsy syndrome	1.78e-05	0.000257	CcSEcCtD
Amoxapine—Hypotension—Topiramate—epilepsy syndrome	1.77e-05	0.000256	CcSEcCtD
Amoxapine—Diazepam—GABRB2—epilepsy syndrome	1.77e-05	0.00782	CrCbGaD
Amoxapine—Asthenia—Pregabalin—epilepsy syndrome	1.76e-05	0.000254	CcSEcCtD
Amoxapine—Pruritus—Pregabalin—epilepsy syndrome	1.74e-05	0.000251	CcSEcCtD
Amoxapine—Diazepam—GABRA1—epilepsy syndrome	1.73e-05	0.00767	CrCbGaD
Amoxapine—Vomiting—Valproic Acid—epilepsy syndrome	1.73e-05	0.000249	CcSEcCtD
Amoxapine—Insomnia—Topiramate—epilepsy syndrome	1.71e-05	0.000247	CcSEcCtD
Amoxapine—Clozapine—CHRM3—epilepsy syndrome	1.71e-05	0.00757	CrCbGaD
Amoxapine—Rash—Valproic Acid—epilepsy syndrome	1.71e-05	0.000247	CcSEcCtD
Amoxapine—Dermatitis—Valproic Acid—epilepsy syndrome	1.71e-05	0.000247	CcSEcCtD
Amoxapine—Headache—Valproic Acid—epilepsy syndrome	1.7e-05	0.000246	CcSEcCtD
Amoxapine—Paraesthesia—Topiramate—epilepsy syndrome	1.7e-05	0.000246	CcSEcCtD
Amoxapine—Somnolence—Topiramate—epilepsy syndrome	1.68e-05	0.000243	CcSEcCtD
Amoxapine—Diarrhoea—Pregabalin—epilepsy syndrome	1.68e-05	0.000243	CcSEcCtD
Amoxapine—Dyspepsia—Topiramate—epilepsy syndrome	1.67e-05	0.000241	CcSEcCtD
Amoxapine—Decreased appetite—Topiramate—epilepsy syndrome	1.64e-05	0.000238	CcSEcCtD
Amoxapine—Fatigue—Topiramate—epilepsy syndrome	1.63e-05	0.000236	CcSEcCtD
Amoxapine—Dizziness—Pregabalin—epilepsy syndrome	1.62e-05	0.000234	CcSEcCtD
Amoxapine—Constipation—Topiramate—epilepsy syndrome	1.62e-05	0.000234	CcSEcCtD
Amoxapine—Asthenia—Gabapentin—epilepsy syndrome	1.61e-05	0.000233	CcSEcCtD
Amoxapine—Nausea—Valproic Acid—epilepsy syndrome	1.61e-05	0.000233	CcSEcCtD
Amoxapine—Clozapine—CHRM1—epilepsy syndrome	1.6e-05	0.00706	CrCbGaD
Amoxapine—Pruritus—Gabapentin—epilepsy syndrome	1.59e-05	0.00023	CcSEcCtD
Amoxapine—Vomiting—Pregabalin—epilepsy syndrome	1.56e-05	0.000225	CcSEcCtD
Amoxapine—Feeling abnormal—Topiramate—epilepsy syndrome	1.56e-05	0.000225	CcSEcCtD
Amoxapine—Loxapine—CHRM2—epilepsy syndrome	1.55e-05	0.00687	CrCbGaD
Amoxapine—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.55e-05	0.000224	CcSEcCtD
Amoxapine—Rash—Pregabalin—epilepsy syndrome	1.55e-05	0.000224	CcSEcCtD
Amoxapine—Dermatitis—Pregabalin—epilepsy syndrome	1.55e-05	0.000223	CcSEcCtD
Amoxapine—Loxapine—HTR7—epilepsy syndrome	1.54e-05	0.00683	CrCbGaD
Amoxapine—Olanzapine—CYP2C19—epilepsy syndrome	1.54e-05	0.00682	CrCbGaD
Amoxapine—Diarrhoea—Gabapentin—epilepsy syndrome	1.54e-05	0.000222	CcSEcCtD
Amoxapine—Headache—Pregabalin—epilepsy syndrome	1.54e-05	0.000222	CcSEcCtD
Amoxapine—Quetiapine—CHRM2—epilepsy syndrome	1.51e-05	0.0067	CrCbGaD
Amoxapine—Quetiapine—HTR7—epilepsy syndrome	1.51e-05	0.00667	CrCbGaD
Amoxapine—Urticaria—Topiramate—epilepsy syndrome	1.5e-05	0.000217	CcSEcCtD
Amoxapine—Abdominal pain—Topiramate—epilepsy syndrome	1.5e-05	0.000216	CcSEcCtD
Amoxapine—Body temperature increased—Topiramate—epilepsy syndrome	1.5e-05	0.000216	CcSEcCtD
Amoxapine—Dizziness—Gabapentin—epilepsy syndrome	1.49e-05	0.000215	CcSEcCtD
Amoxapine—Nausea—Pregabalin—epilepsy syndrome	1.46e-05	0.000211	CcSEcCtD
Amoxapine—Vomiting—Gabapentin—epilepsy syndrome	1.43e-05	0.000207	CcSEcCtD
Amoxapine—Rash—Gabapentin—epilepsy syndrome	1.42e-05	0.000205	CcSEcCtD
Amoxapine—Dermatitis—Gabapentin—epilepsy syndrome	1.42e-05	0.000205	CcSEcCtD
Amoxapine—Headache—Gabapentin—epilepsy syndrome	1.41e-05	0.000204	CcSEcCtD
Amoxapine—Asthenia—Topiramate—epilepsy syndrome	1.36e-05	0.000196	CcSEcCtD
Amoxapine—Pruritus—Topiramate—epilepsy syndrome	1.34e-05	0.000194	CcSEcCtD
Amoxapine—Nausea—Gabapentin—epilepsy syndrome	1.34e-05	0.000193	CcSEcCtD
Amoxapine—Loxapine—ADRA2A—epilepsy syndrome	1.32e-05	0.00586	CrCbGaD
Amoxapine—Zuclopenthixol—HTR2A—epilepsy syndrome	1.31e-05	0.0058	CrCbGaD
Amoxapine—Clozapine—CHRM2—epilepsy syndrome	1.3e-05	0.00577	CrCbGaD
Amoxapine—Clozapine—HTR7—epilepsy syndrome	1.3e-05	0.00574	CrCbGaD
Amoxapine—Diarrhoea—Topiramate—epilepsy syndrome	1.29e-05	0.000187	CcSEcCtD
Amoxapine—Quetiapine—ADRA2A—epilepsy syndrome	1.29e-05	0.00572	CrCbGaD
Amoxapine—Dizziness—Topiramate—epilepsy syndrome	1.25e-05	0.000181	CcSEcCtD
Amoxapine—Olanzapine—HTR2A—epilepsy syndrome	1.25e-05	0.00553	CrCbGaD
Amoxapine—Chlordiazepoxide—CYP2D6—epilepsy syndrome	1.22e-05	0.0054	CrCbGaD
Amoxapine—Vomiting—Topiramate—epilepsy syndrome	1.2e-05	0.000174	CcSEcCtD
Amoxapine—Zuclopenthixol—CYP2D6—epilepsy syndrome	1.2e-05	0.00531	CrCbGaD
Amoxapine—Rash—Topiramate—epilepsy syndrome	1.19e-05	0.000172	CcSEcCtD
Amoxapine—Dermatitis—Topiramate—epilepsy syndrome	1.19e-05	0.000172	CcSEcCtD
Amoxapine—Headache—Topiramate—epilepsy syndrome	1.19e-05	0.000171	CcSEcCtD
Amoxapine—Olanzapine—CYP2D6—epilepsy syndrome	1.14e-05	0.00505	CrCbGaD
Amoxapine—Nausea—Topiramate—epilepsy syndrome	1.12e-05	0.000162	CcSEcCtD
Amoxapine—Clozapine—ADRA2A—epilepsy syndrome	1.11e-05	0.00492	CrCbGaD
Amoxapine—Loxapine—SLC6A4—epilepsy syndrome	1.01e-05	0.00447	CrCbGaD
Amoxapine—Temazepam—CYP2C19—epilepsy syndrome	9.8e-06	0.00434	CrCbGaD
Amoxapine—Quetiapine—CYP2C19—epilepsy syndrome	9.35e-06	0.00414	CrCbGaD
Amoxapine—Olanzapine—ALB—epilepsy syndrome	8.55e-06	0.00378	CrCbGaD
Amoxapine—Olanzapine—ABCB1—epilepsy syndrome	8.16e-06	0.00361	CrCbGaD
Amoxapine—Diazepam—CYP2C19—epilepsy syndrome	8.14e-06	0.0036	CrCbGaD
Amoxapine—Clozapine—CYP2C19—epilepsy syndrome	8.04e-06	0.00356	CrCbGaD
Amoxapine—Loxapine—HTR2A—epilepsy syndrome	7.77e-06	0.00344	CrCbGaD
Amoxapine—Quetiapine—HTR2A—epilepsy syndrome	7.58e-06	0.00335	CrCbGaD
Amoxapine—Quetiapine—CYP2D6—epilepsy syndrome	6.93e-06	0.00307	CrCbGaD
Amoxapine—Clozapine—HTR2A—epilepsy syndrome	6.52e-06	0.00288	CrCbGaD
Amoxapine—Clozapine—CYP2D6—epilepsy syndrome	5.96e-06	0.00264	CrCbGaD
Amoxapine—Quetiapine—ABCB1—epilepsy syndrome	4.95e-06	0.00219	CrCbGaD
Amoxapine—Diazepam—ALB—epilepsy syndrome	4.52e-06	0.002	CrCbGaD
Amoxapine—Diazepam—ABCB1—epilepsy syndrome	4.31e-06	0.00191	CrCbGaD
Amoxapine—Clozapine—ABCB1—epilepsy syndrome	4.26e-06	0.00188	CrCbGaD
Amoxapine—ADRA1A—Signaling Pathways—NGF—epilepsy syndrome	6.24e-07	1.2e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—RELA—epilepsy syndrome	6.22e-07	1.2e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—RELA—epilepsy syndrome	6.22e-07	1.2e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCR5—epilepsy syndrome	6.2e-07	1.2e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	6.19e-07	1.19e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	6.17e-07	1.19e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	6.17e-07	1.19e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	6.16e-07	1.19e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—APOE—epilepsy syndrome	6.14e-07	1.18e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	6.13e-07	1.18e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—PRKCB—epilepsy syndrome	6.13e-07	1.18e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—FGF2—epilepsy syndrome	6.12e-07	1.18e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL6ST—epilepsy syndrome	6.1e-07	1.18e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	6.1e-07	1.18e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—MTOR—epilepsy syndrome	6.1e-07	1.18e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—MTOR—epilepsy syndrome	6.09e-07	1.17e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	6.08e-07	1.17e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCR5—epilepsy syndrome	6.07e-07	1.17e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	6.07e-07	1.17e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	6.06e-07	1.17e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—RELA—epilepsy syndrome	6.05e-07	1.17e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	6.04e-07	1.16e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—RELA—epilepsy syndrome	5.95e-07	1.15e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—HTR2A—epilepsy syndrome	5.94e-07	1.15e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—MTOR—epilepsy syndrome	5.93e-07	1.14e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	5.87e-07	1.13e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	5.86e-07	1.13e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—AGT—epilepsy syndrome	5.85e-07	1.13e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—MTOR—epilepsy syndrome	5.83e-07	1.12e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	5.8e-07	1.12e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—FGF2—epilepsy syndrome	5.77e-07	1.11e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	5.77e-07	1.11e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	5.76e-07	1.11e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	5.75e-07	1.11e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—AGT—epilepsy syndrome	5.75e-07	1.11e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	5.73e-07	1.11e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—APOE—epilepsy syndrome	5.73e-07	1.11e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	5.73e-07	1.1e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—FGF2—epilepsy syndrome	5.69e-07	1.1e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—RELA—epilepsy syndrome	5.68e-07	1.09e-05	CbGpPWpGaD
Amoxapine—HTR6—GPCR downstream signaling—AKT1—epilepsy syndrome	5.66e-07	1.09e-05	CbGpPWpGaD
Amoxapine—HTR7—GPCR downstream signaling—AKT1—epilepsy syndrome	5.66e-07	1.09e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TSC2—epilepsy syndrome	5.65e-07	1.09e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	5.64e-07	1.09e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	5.64e-07	1.09e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—AGT—epilepsy syndrome	5.64e-07	1.09e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—APOE—epilepsy syndrome	5.63e-07	1.09e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—KDR—epilepsy syndrome	5.62e-07	1.08e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	5.61e-07	1.08e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CASP3—epilepsy syndrome	5.61e-07	1.08e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	5.61e-07	1.08e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CASP3—epilepsy syndrome	5.61e-07	1.08e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	5.58e-07	1.08e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—MTOR—epilepsy syndrome	5.57e-07	1.07e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	5.53e-07	1.07e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	5.52e-07	1.06e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	5.52e-07	1.06e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—KDR—epilepsy syndrome	5.52e-07	1.06e-05	CbGpPWpGaD
Amoxapine—HTR1B—GPCR downstream signaling—AKT1—epilepsy syndrome	5.5e-07	1.06e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	5.5e-07	1.06e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	5.49e-07	1.06e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	5.46e-07	1.05e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CASP3—epilepsy syndrome	5.45e-07	1.05e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—JUN—epilepsy syndrome	5.45e-07	1.05e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—JUN—epilepsy syndrome	5.45e-07	1.05e-05	CbGpPWpGaD
Amoxapine—DRD4—GPCR downstream signaling—AKT1—epilepsy syndrome	5.42e-07	1.04e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	5.41e-07	1.04e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	5.41e-07	1.04e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	5.39e-07	1.04e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CASP3—epilepsy syndrome	5.37e-07	1.03e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—RELA—epilepsy syndrome	5.36e-07	1.03e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	5.32e-07	1.03e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	5.31e-07	1.02e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—MMP9—epilepsy syndrome	5.3e-07	1.02e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	5.3e-07	1.02e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—MMP9—epilepsy syndrome	5.3e-07	1.02e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—JUN—epilepsy syndrome	5.3e-07	1.02e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	5.29e-07	1.02e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	5.29e-07	1.02e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—RELA—epilepsy syndrome	5.28e-07	1.02e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—POMC—epilepsy syndrome	5.27e-07	1.02e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	5.27e-07	1.02e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MTOR—epilepsy syndrome	5.25e-07	1.01e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	5.25e-07	1.01e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	5.24e-07	1.01e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	5.22e-07	1.01e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	5.21e-07	1.01e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—JUN—epilepsy syndrome	5.21e-07	1e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	5.21e-07	1e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	5.19e-07	1e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MTOR—epilepsy syndrome	5.18e-07	9.99e-06	CbGpPWpGaD
Amoxapine—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	5.17e-07	9.97e-06	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—MMP9—epilepsy syndrome	5.15e-07	9.93e-06	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CAT—epilepsy syndrome	5.15e-07	9.92e-06	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—AKT1—epilepsy syndrome	5.14e-07	9.91e-06	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—AKT1—epilepsy syndrome	5.14e-07	9.9e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	5.13e-07	9.89e-06	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	5.12e-07	9.87e-06	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—AKT1—epilepsy syndrome	5.11e-07	9.85e-06	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—MMP9—epilepsy syndrome	5.07e-07	9.77e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	5.03e-07	9.69e-06	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	5.01e-07	9.65e-06	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	5e-07	9.63e-06	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	4.98e-07	9.59e-06	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	4.96e-07	9.56e-06	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	4.94e-07	9.51e-06	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—POMC—epilepsy syndrome	4.93e-07	9.5e-06	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—AKT1—epilepsy syndrome	4.92e-07	9.48e-06	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—SRC—epilepsy syndrome	4.89e-07	9.42e-06	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—SRC—epilepsy syndrome	4.88e-07	9.41e-06	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	4.88e-07	9.4e-06	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	4.85e-07	9.34e-06	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	4.84e-07	9.33e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	4.84e-07	9.33e-06	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—POMC—epilepsy syndrome	4.84e-07	9.32e-06	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CASP3—epilepsy syndrome	4.83e-07	9.31e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	4.82e-07	9.29e-06	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	4.82e-07	9.29e-06	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	4.82e-07	9.29e-06	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—AKT1—epilepsy syndrome	4.81e-07	9.27e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—ALB—epilepsy syndrome	4.81e-07	9.27e-06	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CASP3—epilepsy syndrome	4.77e-07	9.19e-06	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—VEGFA—epilepsy syndrome	4.76e-07	9.18e-06	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—VEGFA—epilepsy syndrome	4.76e-07	9.17e-06	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	4.75e-07	9.16e-06	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	4.75e-07	9.15e-06	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	4.74e-07	9.14e-06	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	4.73e-07	9.12e-06	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	4.72e-07	9.09e-06	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	4.7e-07	9.05e-06	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—JUN—epilepsy syndrome	4.69e-07	9.04e-06	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—SRC—epilepsy syndrome	4.68e-07	9.01e-06	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	4.66e-07	8.97e-06	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	4.64e-07	8.95e-06	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—JUN—epilepsy syndrome	4.63e-07	8.92e-06	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	4.63e-07	8.92e-06	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	4.61e-07	8.88e-06	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	4.58e-07	8.83e-06	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MMP9—epilepsy syndrome	4.57e-07	8.8e-06	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—VEGFA—epilepsy syndrome	4.55e-07	8.78e-06	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	4.52e-07	8.71e-06	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MMP9—epilepsy syndrome	4.5e-07	8.68e-06	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	4.49e-07	8.66e-06	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	4.46e-07	8.6e-06	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—AKT1—epilepsy syndrome	4.43e-07	8.53e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	4.41e-07	8.5e-06	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—AKT1—epilepsy syndrome	4.37e-07	8.42e-06	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	4.36e-07	8.4e-06	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	4.35e-07	8.38e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	4.31e-07	8.32e-06	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	4.29e-07	8.26e-06	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	4.28e-07	8.24e-06	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	4.26e-07	8.22e-06	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—SRC—epilepsy syndrome	4.21e-07	8.11e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	4.21e-07	8.11e-06	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	4.2e-07	8.09e-06	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	4.19e-07	8.08e-06	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	4.17e-07	8.04e-06	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	4.15e-07	8.01e-06	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—SRC—epilepsy syndrome	4.15e-07	8e-06	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	4.13e-07	7.97e-06	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—VEGFA—epilepsy syndrome	4.1e-07	7.9e-06	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—AGT—epilepsy syndrome	4.08e-07	7.87e-06	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—VEGFA—epilepsy syndrome	4.04e-07	7.8e-06	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—RELA—epilepsy syndrome	4.04e-07	7.79e-06	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	4.04e-07	7.78e-06	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	4.01e-07	7.74e-06	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—APOE—epilepsy syndrome	4e-07	7.71e-06	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	3.98e-07	7.67e-06	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—RELA—epilepsy syndrome	3.97e-07	7.65e-06	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	3.97e-07	7.64e-06	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	3.96e-07	7.63e-06	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	3.93e-07	7.57e-06	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	3.91e-07	7.53e-06	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	3.9e-07	7.52e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	3.9e-07	7.52e-06	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	3.9e-07	7.51e-06	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	3.89e-07	7.5e-06	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	3.88e-07	7.48e-06	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	3.82e-07	7.36e-06	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	3.81e-07	7.34e-06	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	3.79e-07	7.3e-06	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	3.68e-07	7.1e-06	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	3.65e-07	7.03e-06	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.62e-07	6.98e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	3.62e-07	6.98e-06	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	3.62e-07	6.98e-06	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.61e-07	6.97e-06	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.6e-07	6.94e-06	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	3.6e-07	6.94e-06	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	3.59e-07	6.92e-06	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	3.58e-07	6.9e-06	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	3.57e-07	6.88e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	3.55e-07	6.84e-06	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.55e-07	6.84e-06	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—JUN—epilepsy syndrome	3.54e-07	6.83e-06	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	3.53e-07	6.79e-06	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	3.51e-07	6.77e-06	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	3.51e-07	6.76e-06	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	3.49e-07	6.72e-06	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—JUN—epilepsy syndrome	3.48e-07	6.7e-06	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	3.47e-07	6.68e-06	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	3.45e-07	6.64e-06	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—POMC—epilepsy syndrome	3.44e-07	6.62e-06	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	3.41e-07	6.58e-06	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	3.39e-07	6.54e-06	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	3.38e-07	6.52e-06	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	3.37e-07	6.5e-06	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	3.34e-07	6.44e-06	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	3.32e-07	6.4e-06	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.3e-07	6.35e-06	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	3.29e-07	6.34e-06	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	3.28e-07	6.33e-06	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	3.27e-07	6.31e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	3.27e-07	6.29e-06	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	3.22e-07	6.21e-06	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—SRC—epilepsy syndrome	3.18e-07	6.13e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	3.17e-07	6.11e-06	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—ALB—epilepsy syndrome	3.13e-07	6.04e-06	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	3.13e-07	6.03e-06	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—SRC—epilepsy syndrome	3.12e-07	6.01e-06	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	3.11e-07	5.99e-06	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	3.1e-07	5.97e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	3.09e-07	5.95e-06	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	3.06e-07	5.9e-06	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	3.05e-07	5.87e-06	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	3.04e-07	5.86e-06	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—AKT1—epilepsy syndrome	3.04e-07	5.86e-06	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—AKT1—epilepsy syndrome	3.04e-07	5.85e-06	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	3.03e-07	5.84e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	2.99e-07	5.77e-06	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	2.98e-07	5.75e-06	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	2.95e-07	5.69e-06	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—AKT1—epilepsy syndrome	2.91e-07	5.6e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	2.84e-07	5.48e-06	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	2.77e-07	5.35e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	2.77e-07	5.34e-06	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	2.74e-07	5.28e-06	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—AKT1—epilepsy syndrome	2.62e-07	5.04e-06	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—AKT1—epilepsy syndrome	2.58e-07	4.97e-06	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	2.25e-07	4.34e-06	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	2.24e-07	4.31e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—AKT1—epilepsy syndrome	2.11e-07	4.08e-06	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	1.97e-07	3.81e-06	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	1.94e-07	3.75e-06	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	1.94e-07	3.74e-06	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.93e-07	3.73e-06	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	1.9e-07	3.67e-06	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	1.77e-07	3.41e-06	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.38e-07	2.66e-06	CbGpPWpGaD
